OFM
Omega Fund Management Portfolio holdings
AUM
$154M
This Quarter Return
+6.68%
1 Year Return
-32.78%
3 Year Return
+82.35%
5 Year Return
+29.08%
10 Year Return
+90.46%
AUM
$154M
AUM Growth
+$154M
(-8.9%)
Cap. Flow
-$6.44M
Cap. Flow
% of AUM
-4.17%
Top 10 Holdings %
Top 10 Hldgs %
97.77%
Holding
13
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Nuvation Bio
NUVB
|
$3.96M |
| 2 |
KMTS
Kestra Medical Technologies, Ltd. Common Stock
KMTS
|
$2.49M |
Sector Composition
| 1 | Healthcare | 99.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BBNX
1
Beta Bionics, Inc. Common Stock
BBNX
$819M
| $28.9M | 18.75% | 1,988,287 | – | – |
|
|
KMTS
2
Kestra Medical Technologies, Ltd. Common Stock
KMTS
$829M
| $27.3M | 17.67% | 1,645,893 -150,000 | -8% | -$2.49M |
|
|
UPB
3
Upstream Bio, Inc. Common Stock
UPB
$923M
| $22.4M | 14.48% | 2,036,293 | – | – |
|
|
4
Nuvation Bio
NUVB
$1.02B
| $21.5M | 13.94% | 11,042,728 -2,029,612 | -16% | -$3.96M |
|
|
BCAX
5
Bicara Therapeutics Inc. Common Stock
BCAX
$651M
| $20.5M | 13.26% | 2,204,650 | – | – |
|
6
Replimune Group
REPL
$422M
| $18.3M | 11.88% | 1,975,203 | – | – |
|
7
Lexeo Therapeutics
LXEO
$259M
| $4.76M | 3.08% | 1,184,636 | – | – |
|
|
IMA
8
ImageneBio, Inc. Common Stock
IMA
$150M
| $3.01M | 1.95% | 2,249,123 | – | – |
|
9
Sana Biotechnology
SANA
$777M
| $2.3M | 1.49% | 843,750 | – | – |
|
|
ALMS
10
Alumis Inc. Common Stock
ALMS
$479M
| $1.96M | 1.27% | 653,223 | – | – |
|
11
enGene Holdings
ENGN
$236M
| $1.92M | 1.24% | 526,357 | – | – |
|
12
Immunic
IMUX
$80.9M
| $1.25M | 0.81% | 1,788,160 | – | – |
|
|
13
enGene Holdings Inc. Warrants
ENGNW
$7.08M
| $273K | 0.18% | 321,502 | – | – |
|